Abstract: Despite the great efforts poultry breeding companies made towards eradication of pathogenic mycoplasmas from poultry flocks, Still Mycoplasma gallisepticum (MG) infection is of continuing economic concern in commercial broiler breeder chicken flocks. Control of MG infection in broiler breeder chicken flocks by chemotherapy is the most practical way to minimize economical losses. Tilmicosin is one of the most important antimicrobial agent used for treatment and control of MG infection. This study was carried out on eight broiler breeder chicken flocks with a history of MG challenge {signs, post mortem, and serology [enzyme linked immunosorbent assay (ELISA)]}. Tilmicosin (Provitil powder® 30 mg/kg body weight) was used to limit MG infection in these flocks, and was given to birds for 3 successive days every 5 weeks for 4 months. 136 serum samples were collected from these flocks (16-18 samples per flock) before starting tilmicosin treatment and the same number of serum samples were collected following each three treatment course at 5 weeks interval. Mycoplasma gallisepticum ELISA was performed on these samples for the purpose of detecting MG antibodies in these flocks and analyzing data subsequently. The first and second course of tilmicosin treatment did not have any significant effect on MG ELISA results (GMT) (P>0.05), while after the third course, GMT had dropped significantly (P<0.05) in all tested flocks compared to results gained prior starting treatment with tilmicosin. The overall sero-prevalence of MG in broiler breeder chicken population involved in the study was 80.43% and 44.09% before and after completing medication with tilmicosin respectively, while the percentage of antibody positive chickens among flock samples ranged from 38.88-100% and 18.75-56.25% before and after complete medication with tilmicosin respectively (P<0.05). Improvement in reproductive performances was observed (decreased mortality, increased feed intake and increased egg production and hatchability). The overall data presented here indicated that Provitil® (30 mg/kg body weight for 3 successive days every 5 weeks for 4 months) is considered a highly effective therapeutic in MG control programs for broiler breeder chicken flocks, and has a net positive effect for the producer. Further studies are necessary to assesses economic losses due to MG and the cost benefit o f countermeasures.
Introduction
Mycoplasma gallisepticum (MG) infection is responsible for significant economical losses in commercial broiler breeder chicken flocks industry (Carpenter et al., 1979 , Yoder, 1991 Evans and Hafez, 1992) . Typically, infected flocks with MG exhibit increased mortality, increased feed conversion ratios, decreased egg production and hatchability, and respiratory disease (Yoder, 1991; Kleven, 1998; Levisohn and Kleven, 2000) . Clinical signs may be exacerbated by viruses or bacteria such as a paramyxovirus or Haemophilus paragallinarium (Yoder, 1991) . Production losses between 10 and 20% have been reported in layers and broiler breeder chicken flocks infected with MG (Bradbury, 2001) . Mycoplasma gallisepticum infections are transmitted both horizontally and vertically and it remains in the flock constantly as sub clinical form (Bencina et al., 1988a) . Attempts to control this organism must be balanced against the need for greater efficiency in production costs. Control of avian mycoplasmosis infection by vaccination is limited as only few vaccines are available. Total eradication through test and slaughter is the most effective control method (Yoder, 1991) , not only this is expensive but also the emergence of multiage complexes in the commercial layer industry makes this approach impractical (Evans and hafez, 1992; Levisohn and Kleven, 2000) . Control of MG infection in broiler breeder by chemotherapy is the most practical way to minimize economical losses. The most important antimicrobial agent used for treatment and control of MG infection is tilmicosin. Tilmicosin is a broad-spectrum bacteriostatic synthesized from tylosin for veterinary use only. It has an antibacterial spectrum that is predominantly effective against Mycoplasma spp, Pasteurella spp, and various Gram-positive organisms (Prescott, 2000) . It has been tilmicosin treatment and the other three visits were used extensively to treat respiratory disease in swine, carried out every 5 weeks of treatment. 136 serum cattle and sheep (Moore et al., 1996; Hoar et al., 1998;  samples were collected at each visit (16-18 samples Christodoulopoulos et al., 2002) Tilmicosin is licensed per each flock) and questionnaires were filled. Each for treatment and control of respiratory diseases house in the farm was given a certain number then a associated with MG, Mycoplasma synoviae, number was drawn from each farm to be sampled.
Ornithobacterium rhinotracheale and Pasteurela
Three parallel imaginary lines were drafted along the multacida in chickens (Jordan and Horrocks, 1996;  length of the house (left, right and center) 5-6 birds were Kempf et al., 1997; EMEA, 1998; Varga et al., 2001) . The picked up along one walk covering the length of the present study was conducted to evaluate the effects of house using each of the three lines, then blood was giving tilmicosin (Provitil® powder) at a dose rate of collected from these birds by veno-puncture of the wing 30 mg/kg body weight (bw) for 3 successive days vein. All blood samples were collected from these flocks repeated every 5 weeks for 4 months to broiler breeder were submitted immediately to Provimi Jordan chicken flocks exposed to MG.
Laboratories (ISO 17025 accredited) for analysis. Flocks history: None of the breeder flocks included in this study had received any vaccination against MG. The majority of these flocks had exhibited a decrease in feed intake, egg production (10-11%) and hatchability (8%) and increase in mortality (3%) over a period of less than 1 wk. On physical examination, birds appeared healthy and had good flesh, with a slight suborbital sinus swelling noted. Tracheitis, mild airsacculitis and salpingitis were seen on necropsy. All flocks included in
Materials and Methods

Flocks
Results and Discussion
this study were tested by ELISA for the presence of MG None of the flocks involved in the current study were less antibodies at one day old and were found negative.
than 5 weeks of age nor were they vaccinated against Blood sample: All eight broiler breeder chicken flocks indicate a field exposure to MG and exclude that the chosen for performing this study were contacted through detected antibodies are maternal antibodies or resulted appropriate veterinarians. Each farm in the study was from vaccination. visited four times; the first was just before starting
The majority of flocks (No. 2, 3, 5, 6, 7, 8) , had high Drug: Provitil® (tilmicosin phosphate powder (300 mg/gm), Provimi Jordan, Amman Jordan) was used in this study. Provitil® was given according to manufacturer instructions (30 mg/kg body weight for 3 successive days). The recommended dose was repeated every 5 weeks for 4 months.
Enzyme-linked immunosorbent assay (ELISA):
The serum samples were given a specific code number for each flock, and were kept frozen at -20 C till until o analysis. A commercial test kit was used to detect specific antibodies against MG based on indirect enzyme linked immunosorbent assay (Synbiotics Corporation, ProFlock KPL, USA). A final serum dilution of 1:100 was used according to the manufacturer instructions. All collected serum samples from each flock (before and three course of medication with tilmicosin) were run in the same test plate to prevent conclusions error that may due to day variation of the test (Kreider et al., 1991 a,b) . Positive and negative reference controls provided by the manufacturer were also used in each test run for quality control and confirmation of the results. Optical density values were set at 405 nm wave length using an ELx800 ELISA reader (BIO-TEK Instruments, Inc. Winooski, VT, USA).
Statistical analysis: ELISA geometric mean titer (GMT) before, first, second, and third treatment with tilmicosin were compared by means of the Chi-square test. A significant level of 5% was used. Statistical analysis was performed with the SAS 8.2 package (SAS Institute, 1999).
MG. Therefore, antibodies detected in the first set of sera geometric mean titers (GMT) (>1000) before starting results (GMT) (P>0.05), while after the third course, GMT tilmicosin treatment program. This indicated an infection had dropped significantly (P<0.05) in all tested flocks with highly pathogenic strains of MG, while for flocks compared to results gained prior starting treatment with No.1 and 4, the GMT titers was low (<500) before tilmicosin (Table 1 and Fig. 1 ). The highest starting treatment, which reflected either an initial stage seroprevalence (100%) was in flocks no 7 and 8 before of infection, or an exposure to low pathogenic M G starting tilimicosin treatment, while after third treatment strains. The first and second course of tilmicosin with tilmicosin, it dropped significantly into 56.25% for treatment did not have any significant effect on MG ELISA flock no.7 and 68.75% for flock no.8 (P<0.05). All tested During the period in which this study was conducted, there was a gradual increase in egg production (5-6 eggs per hen) in all flocks included in this study. This comes in agreement with previous reports on the effect of tilmicosin treatment on egg production in layers and breeder chicken flocks which resulted in producing 6 or more eggs per hen compared to non treated hen (Charleston et al., 1984 , Bradbury, 2001 ). Other criteria of r eproductive performance such as hatchability, mortality, feed intake, and livability of progeny had also improved (data is not show).
The ELISA results in the current study provide evidence of the wide distribution of MG and of a considerably high incidence of infection among broiler breeder chicken flocks in Jordan; this comes in agreement with a previous study Roussan and Gharibeh (2005) which showed that the prevalence of MG in broiler, layer, and broiler breeder chicken flocks in Jordan were 70.4%, 80%, and 71.4% respectively. This high prevalence confirms the endemic nature of the disease in Jordan.
Mycoplasma gallisepticum seroprevalence in chickens has been reported to be high in many countries with no control strategies or in countries before the implementation of control strategies. For example, MG seroprevalence was 73% in layers in Southern California in 1986 (Mohammed et al., 1986) . In Aragua State, Venezuela, seroprevalence of MG in layers was 59% and 66% in two different municipalities (Godoy et al., 2001 ). There were reports of MG seroprevalence of 53% in broilers in Mongolia (Zhang et al., 2001) , 47.5% in Zaria, Nigeria (Abdu et al., 1993) and 10-13% in Croatia (Zelenika et al., 1999) . A review of current literature reveals a number of articles suggesting the use of antibiotics to control poultry mycoplasmosis. Tilmicosin was among these antibiotics, were used effectively in treatment programs to r educe losses associated with mycoplasmosis (Evans and Hafez, 1992; Jordan and Horroks, 1996; Hoar et al., 1998; Levisohn and Kleven, 2000) . Abu Basha et al. (2006) investigated the pharmacokinetics and tissue concentrations of two formulations o f tilmicosin (Provitil® [tilmicosin phosphate powder 300 mg/gm, Provimi Jordan, Amman Jordan] and Pulmotil® AC ([tilmicosin phosphate liquid 250 mg/ml, ELANCO Animal health, Div. Eli Lily, Geneva, Switzerland]), after oral administration of a single dose (30 mg/kg body weight) in chickens, they concluded that, tilmicosin was rapidly absorbed, slowly eliminated, and he also showed that the peak plasma concentration detected in chickens after oral administration of Provitil® (30 mg/kg body weight) was 2.12 ± 0.40 µg/ml. These values were higher than the minimum inhibition concentrations (MICs) for Ornithobacterium rhinotracheal (0.06-1 µg/ml) (Varga et al., 2001) and Mycoplasma gallisepticum and M. synoviae (0.0125-0.1 µg/ml) and lower than MICs for Clostridium perfringens strains isolated from commercial broiler farms (Watkins et al., 1997) . Keles et al. (2001) investigated the pharmacokinetics and tissue concentrations after oral administration of a single dose of tilmicosin (50 mg/kg b.w.) in fowls and concluded that; tilmicosin was slowly eliminated from serum and lung with mean half-lives of 30.18 ± 2.38 and 75.74 ± 3.67 hour, respectively. The mean peak concentration o f tilmicosin was 6.2 greater in the lung (7.96 ± 0.30 µg/ml) than that in serum (1.28 ±0.04 µg/ml) and reached peak concentration at 4.66 ± 2 and 17.78 ± 7.51hour, respectively. The NCCLS guidelines for tilmicosin susceptibility list a breakpoint of < 8 µg/ml (Watts, 1999) . This clearly demonstrates that the serum concentrations of tilmicosin are lower than the MICs for some susceptible bacteria. Nevertheless, several studies demonstrated that administration of tilmicosin at the recommended dose is effective for control of respiratory disease in several animal species (Moore et al., 1996; Christodoulopoulos et al., 2002) . The high success rate of treatment is due to the prolong presence o f therapeutic concentrations of tilmicosin in the lung tissues (Papich and Riviere, 2001 ). The concentration of Carpenter, T.E., K.F. Miller, R.F. Gentry, L.D. Swartz and tilmicosin in rats' lungs was higher than the serum tilmicosin at all tested times and the infected rats with Mycoplasma pulmonis had higher lung tilmicosin concentration than non-infected rats (Modric et al., 1998) . This phenomenon was also seen in lung tissues o f chickens, swine and cattle (Scorneaux and Shryock, 1998a; 1998b; . The results of this study provided serological evidence on the effectiveness of using Provitil® (30 mg/kg body weight for 3 successive days repeated every 5 weeks for 4 months) in treatment and control of MG infection in broiler breeder chicken flocks and suggest a Mycoplasmacidal effect of tilmicosin which agrees with previous report on the high success rate of tilmicosin treatment due to prolonged presence of therapeutic concentration of tilmicosin in lung tissues (Papich and Riviere, 2001) . The overall data presented here indicates that Provitil® (30 mg/kg body weight for 3 successive days every 5 weeks for 4 months) is considered a highly effective therapeutic in MG control programs for breeder chicken flocks, and has a net positive effect for the producer through slowed the rate of spread of M G infection within flocks, increasing in eggs production, and hatchability, and reducing mortality. However it is also important to consider eliminating other factors (stress, and viral problem) that may have a direct effect on flock health status.
